Gujarat Kidney And Super Speciality Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹108 - ₹114
- Lot size
- 128 shares
- Issue amount
- ₹250.8 cr
- Total subscription
- 5.21×
- Opens
- 22 Dec 2025
- Closes
- 24 Dec 2025
- Allotment
- 26 Dec 2025
- Listing
- 30 Dec 2025
Offer at a glance
Issue overview
- Issue size
- 2,20,00,000 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹13,824
- Fresh issue
- ₹250.8 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,592
- Issue type
- Bookbuilding IPO
- Shares before issue
- 5,68,43,250
- Shares after issue
- 7,88,43,250
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 128 | ₹14,592 |
| sHNI | 14 | 1,792 | ₹2,04,288 |
| bHNI | 69 | 8,832 | ₹10,06,848 |
Share reservation
Subscription & GMP
Subscription by category
Reported 24 Dec 2025
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 17,188 | 2,57,518 |
| HNIs(10L +) | 1,228 | 1,275 |
| HNIs (2-10L) | 614 | 3,680 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 88.09 | 93.35 |
| Others | 0 | 0.02 |
| RETAIL | 25.08 | 477.44 |
| HNIs 2+ | 12.54 | 83.76 |
| HNIs 10+ | 25.08 | 131.7 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| EPS | 0 | 0 | 0 | 0 |
| ROE | 15.85 | 36.61 | 15.86 | -1.67 |
| ROCE | 18.91 | 37.65 | 9.79 | -1.7 |
| RONW | 0 | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 61.22 | 0 | 0 |
| POST IPO(PE) | 41.59 | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Gujarat Kidney & Super Speciality Limited | 61.22 | 0 | 2 | 5.04 | 36.61 | 1.85 |
| Kmc Speciality Hospitals (india) Ltd | 52.6 | 69.00 | 1 | 10.08 | 13.04 | 1.31 |
| Gpt Healthcare Limited | 24.51 | 149 | 10 | 30.21 | 20.14 | 6.08 |
| Yatharth Hospital & Trauma Care Services Limited | 55.84 | 822 | 10 | 166.62 | 8.13 | 14.72 |
Company information
Company profile
Gujarat Kidney and Super Speciality Limited, incorporated in 2019, provides multispeciality healthcare services across Gujarat through a network of seven hospitals and four pharmacies, offering secondary and tertiary care. The company operates a total bed capacity of 490 beds, with 455 approved and 340 operational, across facilities in Vadodara, Godhra, Bharuch, Borsad, and Anand. Its services cover general and surgical treatments as well as super speciality procedures, including internal medicine, general and minimally invasive surgery, orthopaedics and trauma care, joint replacement, obstetrics and gynaecology, respiratory care, cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company’s operations are supported by 89 doctors, 332 nurses, and 338 other staff members.
Strengths
- Strong Specialisation in Renal Care – Well-established expertise in renal sciences with advanced sub-specialities, supported by multispeciality hospitals delivering tertiary healthcare services.
- Asset-Light Hospital Operating Model – Hospitals are run through leased and majority-owned entities, allowing expansion with lower capital investment in land and infrastructure.
- Ability to Attract and Retain Medical Professionals – Low attrition among doctors and nurses reflects success in building a stable, skilled workforce through a high-volume, multidisciplinary care approach.
Risk factors
- Risk in Acquisition of Parekhs Hospital – Any difficulty in completing the planned 100% acquisition using issue proceeds may disrupt future growth plans and operational strategy.
- Funding Risk for Ashwini Medical Centre Acquisition – Delays in raising funds for part-payment of the already acquired Ashwini Medical Centre may affect timely settlement with sellers.
- Execution Risks in New Hospital Expansion – Setting up the proposed women’s healthcare hospital in Vadodara faces approval delays, equipment procurement challenges, cost escalation, and lease-related risks that may impact expansion timelines and financial performance.
Promoters
Dr. Pragnesh Yashwantsinh Bharpoda
Dr. Bhartiben Pragnesh Bharpoda
Dr. Yashwantsingh Motisinh Bharpoda
Anitaben Yashwantsinh Bharpoda
Registrar & documents
Lead manager
Nirbhay Capital Services Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat, 390020
+91 265 298 4800
[email protected]Company website ↗Understanding GKSL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.